These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2845532)

  • 21. [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
    Sampi K; Maseki N; Hattori M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):823-6. PubMed ID: 1605660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective parenteral and enteral antisepsis regimen (SPEAR).
    Gould IM
    Br J Hosp Med; 1990 Sep; 44(3):209-11. PubMed ID: 2257406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
    Sleijfer DT; Mulder NH; de Vries-Hospers HG; Fidler V; Nieweg HO; van der Waaij D; van Saene HK
    Eur J Cancer (1965); 1980 Jun; 16(6):859-69. PubMed ID: 6997054
    [No Abstract]   [Full Text] [Related]  

  • 24. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome.
    Buchanan AG; Riben PD; Rayner EN; Parker SE; Ronald AR; Louie TJ
    Clin Invest Med; 1985; 8(2):139-47. PubMed ID: 3879598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic oral antibiotics in the management of acute leukaemia.
    Levi JA; Vincent PC; Jennis F; Lind DE; Gunz FW
    Med J Aust; 1973 May; 1(21):1025-9. PubMed ID: 4718495
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective intestinal decontamination of the digestive tract for infection prophylaxis in severely burned patients.
    Manson WL; Westerveld AW; Klasen HJ; Sauër EW
    Scand J Plast Reconstr Surg Hand Surg; 1987; 21(3):269-72. PubMed ID: 2831622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination.
    Kurrle E; Bhaduri S; Krieger D; Pflieger H; Heimpel H
    Klin Wochenschr; 1983 Jul; 61(14):691-8. PubMed ID: 6887757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies on cefoperazone and polymyxin B for the treatment of infections in patients with hematological malignancies].
    Hara M
    Jpn J Antibiot; 1987 Sep; 40(9):1639-43. PubMed ID: 2826837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of selective bowel decontamination as infection prevention after liver transplantation.
    Rosman C; Klompmaker IJ; Bonsel GJ; Bleichrodt RP; Arends JP; Slooff MJ
    Transplant Proc; 1990 Aug; 22(4):1554-5. PubMed ID: 2389398
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.
    Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
    Ann Intern Med; 1987 Jan; 106(1):1-7. PubMed ID: 3538962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
    Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K
    J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of gastrointestinal decontamination under protected environment].
    Nagao T; Yonekura S; Komatsuda M; Nozaki H; Arimori S; Sawamura S; Ozawa A; Sasaki S
    Kansenshogaku Zasshi; 1991 Jan; 65(1):40-6. PubMed ID: 2066589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
    Hann IM; Prentice HG; Corringham R; Blacklock HA; Keaney M; Shannon M; Noone P; Gascoigne E; Fox J; Boesen E; Szawatkowski M; Hoffbrand AV
    Lancet; 1982 Apr; 1(8276):826-9. PubMed ID: 6122057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of selective decontamination on antimicrobial resistance.
    Hammond JM; Potgieter PD
    Crit Care Med; 1995 Apr; 23(4):637-45. PubMed ID: 7712753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
    Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
    J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens.
    Camus C; Bellissant E; Sebille V; Perrotin D; Garo B; Legras A; Renault A; Le Corre P; Donnio PY; Gacouin A; Le Tulzo Y; Thomas R
    Crit Care Med; 2005 Feb; 33(2):307-14. PubMed ID: 15699832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.
    Bodey GP; Anaissie EJ; Elting LS; Estey E; O'Brien S; Kantarjian H
    Cancer; 1994 Apr; 73(8):2099-106. PubMed ID: 8156515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.